X0306 4 2021-12-30 0 0001831097 agilon health, inc. AGL 0001855972 Halkias Theodore C/O AGILON HEALTH, INC. 1 WORLD TRADE CENTER, SUITE 2000 LONG BEACH CA 90831 0 1 0 0 Chief Business Officer Common Stock 2021-12-30 4 M 0 12113 1.00 A 17547 D Common Stock 2021-12-30 4 S 0 12113 27.54 D 5434 D Common Stock 2021-12-31 4 M 0 1162 1.00 A 6596 D Common Stock 2021-12-31 4 S 0 1162 27.55 D 5434 D Options (Rights to Buy) 1.00 2021-12-30 4 M 0 12113 0.00 D 2027-04-27 Common Stock 12113 1702609 D Options (Rights to Buy) 1.00 2021-12-31 4 M 0 1162 0.00 D 2027-04-27 Common Stock 1162 1701447 D Includes restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. /s/ Lyn Amor Macaraeg, as Attorney-in-Fact 2022-01-03